ATDC
VC Fund
Atlanta, United States
ATDC is a VC fund in Atlanta focused on Manufacturing and Medical. Atdc Helps Entrepreneurs Launch And Build Transformative Technology Companies. Atdc Increases An Entrepreneur’S Likelihood Of Success By Orchestrating Connections To Coaching, Capital, Customers And Campus Resources & Talent.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries ATDC invests in
Stages ATDC invests in
Countries ATDC invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Betsy Plattenburg
|
|||
Brian Arnberger
|
|||
Brooke Smith
|
|||
Ivy Hughley
|
|||
John Avery
|
|||
| See all 9 contacts → | |||
Investment Focus
Industry
- Manufacturing 4 (25%)
- Medical 3 (19%)
- Health Care 3 (19%)
- SaaS 2 (13%)
- Software 2 (13%)
Stage
- Funding Round 7 (44%)
- Series B 3 (19%)
- Series C 2 (13%)
- Seed 1 (6%)
- Grant 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Betsy Plattenburg
Community Catalyst
|
Community Catalyst | Total investments: 0 | Find email | |
|
Brian Arnberger
Mentor
|
Mentor | Total investments: 0 | Find email | |
|
Brooke Smith
Client Support Coordinator
|
Client Support Coordinator | Total investments: 0 | Find email | |
|
Ivy Hughley
Membership Manager
|
Membership Manager | Total investments: 0 | Find email | |
|
John Avery
Director
|
Director | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ProcessMiner
|
ProcessMiner offers a predictive system that addresses issues before they arise by providing suggestions and prompting action. It keeps speed and product quality while minimizing the use of raw materials and other costs. They provide services to a variety of industries, including cement, water, polymers, and chemicals. | Non-equity Assistance / Aug 03, 2021 | |
Dr. Noze Best
|
Dr. Noze Best develops a battery-powered suction device designed to clear nasal congestion for babies and children. It is used to suck air through the nose to clear the blocked nasal passages during a cold or nasal infection caused by the respiratory syncytial virus. The company was founded in 2019 and is based in Atlanta, Georgia. | Grant / Feb 01, 2021 | |
Predikto
|
Predikto has developed a software platform that automates up to 80% of the process to create classification machine learning algorithms to predict failures in industrial equipment. Big expensive transportation assets or highly distributed equipment is our sweet spot due to the high cost of downtime | $3.6M / Jan 01, 2015 | |
PURSUANT HEALTH
|
Based in Atlanta, Georgia, Pursuant Health's purpose is to engage individuals to manage their health and improve outcomes. In summer 2010, the Company received a grant from the National Institutes of Health (NIH), a division of the U.S. Department of Health and Human Services, to help develop a self-service health kiosk. PursuantHealth's platform consists of multiple channels, including a unique kiosk network of over 3,600 FDA-cleared, HIPAA-compliant self-service medical devices located within 10 miles of 79% of the U.S. population. For more information, please visit www.pursuanthealth.com. | $12M / Jul 25, 2012 | |
Preparis
|
Preparis provides integrated, on-demand emergency preparedness software and services to help companies around the world prepare and respond to crisis events, ensuring workforce safety, minimizing operational downtime, and maintaining corporate reputation and shareholder value.Preparis' emergency preparedness solutions are widely used byglobal organizations and small and medium businesses alike. Headquartered in Atlanta, Preparis currently safeguards more than 500,000 people and in excess of $185 billion in enterprise value. | $4.6M / Sep 30, 2009 | |
Visioneering
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop productsthat will ultimately enhance practitioner and patient experiences. VTI was founded by Dr. Richard A. Griffin, an optometrist, optical engineer and aerospace engineer who has spent 20 years developing VTI’s optical solutions. From Dr. Griffin's design, VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories. VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism. | $5M / May 11, 2009 | |
Iconic Therapeutics
|
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells toselectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular degeneration (wet AMD) and TF-expressing cancer cells and tumor-associated pathologic blood vessels (PBV). In addition to this cell-mediated cytotoxicity, hI-con1 may also interrupt the positive feedback loop between tissue factor and vascular endothelial growth factor (VEGF), thereby reducing VEGF levels. Phase 1 studies with hl-con1 are complete and no dose limited toxicities were observed. Evidence of dose-related biologic activity was observed. | $2.5M / Jan 17, 2009 | |
ProFounder
|
ProFounder is a crowdfunding platform that enables entrepreneurs to raise investment capital from friends, family, and community members. | Seed / Apr 04, 2008 | |
Altiris Therapeutics
|
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia. | $35M / Series B / Oct 09, 2007 | |
EG Technology
|
EG technology is a video processing tech platform based in Atlanta, GA. | $5M / Series C / Jun 26, 2007 | |
| See all 16 investments → | |||
Co-Investors
H.I.G. Capital
5 deals together
Atlanta Technology Angels
3 deals together
Cordova Ventures
3 deals together
Imlay Investments
3 deals together
Kinetic Ventures
3 deals together
Commonwealth Capital Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does ATDC invest in?
ATDC invests primarily in Manufacturing, Medical and Health Care startups, most often at Funding Round and Series B stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact ATDC?
Public channels for ATDC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ATDC?
The team at ATDC includes Betsy Plattenburg (Community Catalyst), Brian Arnberger (Mentor) and Brooke Smith (Client Support Coordinator), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
